A detailed history of Artisan Partners Limited Partnership transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 1,329,279 shares of RNA stock, worth $54.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,329,279
Previous 1,902,065 30.11%
Holding current value
$54.9 Million
Previous $77.7 Million 21.42%
% of portfolio
0.1%
Previous 0.12%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$37.21 - $48.14 $21.3 Million - $27.6 Million
-572,786 Reduced 30.11%
1,329,279 $61.1 Million
Q2 2024

Aug 12, 2024

SELL
$22.73 - $40.85 $9.65 Million - $17.3 Million
-424,436 Reduced 18.24%
1,902,065 $77.7 Million
Q1 2024

May 13, 2024

BUY
$9.16 - $25.52 $2.05 Million - $5.7 Million
223,479 Added 10.63%
2,326,501 $59.4 Million
Q4 2023

Feb 12, 2024

SELL
$4.87 - $9.37 $247,766 - $476,708
-50,876 Reduced 2.36%
2,103,022 $19 Million
Q2 2023

Aug 10, 2023

BUY
$10.62 - $17.34 $2.64 Million - $4.31 Million
248,577 Added 13.05%
2,153,898 $23.9 Million
Q1 2023

May 11, 2023

BUY
$15.35 - $25.65 $9.28 Million - $15.5 Million
604,345 Added 46.45%
1,905,321 $29.2 Million
Q4 2022

Feb 10, 2023

BUY
$10.06 - $22.66 $9.16 Million - $20.6 Million
910,048 Added 232.79%
1,300,976 $28.9 Million
Q3 2022

Nov 10, 2022

SELL
$15.46 - $23.43 $37,304 - $56,536
-2,413 Reduced 0.61%
390,928 $6.38 Million
Q2 2022

Aug 12, 2022

BUY
$11.18 - $20.5 $4.4 Million - $8.06 Million
393,341 New
393,341 $5.72 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.15B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.